How Targeted Workforce Development Programs Can Support Derisking the Direct Materials Supply Chain | CPhI North America

 

View, browse and sort the ever-growing list of sessions by pass type, track, and format. With this Session Scheduler, you can build your schedule in advance and access it during the show via export or with the Mobile App, once live. Sessions do fill up and seating is first come, first serve, so arrive early to sessions that you would like to attend.

How Targeted Workforce Development Programs Can Support Derisking the Direct Materials Supply Chain

Mary Lynne Bercik (PMP, PMI-RMP, CPSM, Executive Director, Merck Pharmaceuticals)

Location: E353a

Date: Wednesday, May 1

Time: 10:30am - 11:15am

Track: Bio-Processing Symposium

Vault Recording: TBD

  • How do we derisk the Direct Materials Supply Chain?.
    Chinese deregulations, Brexit, Custom IP, silicone shortages...
  • Looking at an E2E approach to ensure assurance of supply
    R&D/NME declaration through Commercial launch
  • Who is involved in derisking the Direct Materials Supply Chain?
  • Functional support; Technical, Quality, Regulatory, Safety and Compliance, Materials Management...
  • How do we Develop BioPharm Talent to ensure they support a derisking model?
  • Targeted training centers that specialize in the complexities found in this highly regulated environment
  • What does BioPharm Talent look like as we pivot into Gene and Cell Therapy and ultimately personalized medicine?
  • Combination workforce applications - marrying the technically trained (STEM) with the design/innovation minds